Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Hypertension drug may help reverse deadly lung tissue scarring

19

Nov 2026

Hypertension drug may help reverse deadly lung tissue scarring

Pulmonary fibrosis is a chronic disease in which lung tissue becomes inflamed, scarred, and stiff. The cause is often unknown, but the resulting damage can be deadly. A Yale School of Medicine study published Nov. 18 in Science Translational Medicine could be the first step toward reversing the disease.

Group exercise helps strengthen social ties, study shows

19

Nov 2026

Group exercise helps strengthen social ties, study shows

If you've been thinking about joining one of the social running, walking or hiking clubs popping up on your social media feeds, new research from The Ohio State University offers another reason to give it a try: Working out with other people might serve as a social lubricant.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.